Sponsor-Investigators

Paul Mathew

HCRN-GU14-202

Combined Targeting of the Androgen Receptor in Metastatic Castrate-Resistant Prostate Cancer with Enzalutamide and the Poly (ADP-Ribose) Polymerase [PARP] Inhibitor Niraparib

Status

Closed

Cancer Types

Prostate

Locations